BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21863089)

  • 1. β‑Propiolactone.
    National Toxicology Program
    Rep Carcinog; 2011; 12():366-7. PubMed ID: 21863089
    [No Abstract]   [Full Text] [Related]  

  • 2. ß-Propiolactone.
    National Toxicology Program
    Rep Carcinog; 2004; 11():III225-6. PubMed ID: 21105255
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethylene oxide.
    Rep Carcinog; 2004; 11():III118-22. PubMed ID: 21089875
    [No Abstract]   [Full Text] [Related]  

  • 4. Formaldehyde (gas).
    Rep Carcinog; 2004; 11():III125-7. PubMed ID: 21089879
    [No Abstract]   [Full Text] [Related]  

  • 5. Tobacco-related exposures: smokeless tobacco.
    National Toxicology Program
    Rep Carcinog; 2011; 12():412-4. PubMed ID: 21863110
    [No Abstract]   [Full Text] [Related]  

  • 6. Trichloroethylene.
    National Toxicology Program
    Rep Carcinog; 2011; 12():420-4. PubMed ID: 21863114
    [No Abstract]   [Full Text] [Related]  

  • 7. Thioacetamide.
    National Toxicology Program
    Rep Carcinog; 2011; 12():403-4. PubMed ID: 21863105
    [No Abstract]   [Full Text] [Related]  

  • 8. o‑Toluidine and its hydrochloride.
    National Toxicology Program
    Rep Carcinog; 2011; 12():416-8. PubMed ID: 21863112
    [No Abstract]   [Full Text] [Related]  

  • 9. Tetrachloroethylene.
    National Toxicology Program
    Rep Carcinog; 2011; 12():398-401. PubMed ID: 21863102
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to Crump et al.
    Starr TB; Swenberg JA
    Regul Toxicol Pharmacol; 2014 Dec; 70(3):737-8. PubMed ID: 25455228
    [No Abstract]   [Full Text] [Related]  

  • 11. beta-Propiolactone.
    National Toxicology Program
    Rep Carcinog; 2002; 10():207-8. PubMed ID: 15334719
    [No Abstract]   [Full Text] [Related]  

  • 12. Wood dust.
    National Toxicology Program
    Rep Carcinog; 2011; 12():442-4. PubMed ID: 21863123
    [No Abstract]   [Full Text] [Related]  

  • 13. The "bottom-up" approach does not necessarily bound low-dose risk.
    Crump KS; Bussard DA; Chen C; Jinot J; Subramaniam R
    Regul Toxicol Pharmacol; 2014 Dec; 70(3):735-6. PubMed ID: 25455229
    [No Abstract]   [Full Text] [Related]  

  • 14. Polybrominated biphenyls.
    National Toxicology Program
    Rep Carcinog; 2011; 12():347-9. PubMed ID: 21863083
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenacetin and analgesic mixtures containing phenacetin.
    National Toxicology Program
    Rep Carcinog; 2011; 12():340-1. PubMed ID: 21863078
    [No Abstract]   [Full Text] [Related]  

  • 16. [The power of numbers].
    Gennaro V
    Epidemiol Prev; 2005; 29(3-4):133-4. PubMed ID: 16454402
    [No Abstract]   [Full Text] [Related]  

  • 17. [Weak carcinogen protects against the effect of strong carcinogen not requiring the metabolic activation].
    Kaledin VI; Vasiunina EA; Morozkova TO; Slyn'ko NM; Liakhovich VV
    Biull Eksp Biol Med; 1998 Dec; 126(12):673-5. PubMed ID: 9934517
    [No Abstract]   [Full Text] [Related]  

  • 18. [A negatively biased inflexibility may lead into ambiguity].
    Tomatis L
    Epidemiol Prev; 2005; 29(3-4):131-2. PubMed ID: 16454401
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethylene oxide.
    National Toxicology Program
    Rep Carcinog; 2011; 12():188-91. PubMed ID: 21852837
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigating cancer risks related to asbestos and other occupational carcinogens.
    Siemiatycki J
    Occup Environ Med; 2007 Aug; 64(8):500-1. PubMed ID: 17634249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.